Summary:
Study to compare the safety and efficacy profiles of Perrigo UK FINCO, Ivermectin Cream,1% to Galderma Laboratories Soolantra (Ivermectin) Cream 1% and to Demonstrate the superior efficacy of 2 active formulations over placebo in the treatment of inflammatory Lesions of Rosacea.
Qualified Participants Must:
• Be 18 years of age or older
•
Have moderate to revere Rosacea
Qualified Participants May Receive:
study medication or placebo and study related office visits at no cost. Qualified Participants will be compensated up to $200 for time and travel.